Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.

@article{Tamaki2009CardiacIM,
  title={Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.},
  author={Shunsuke Tamaki and Takahisa Yamada and Yuji Okuyama and Takashi Morita and Shoji Sanada and Yasumasa Tsukamoto and Masaharu Masuda and Keiji Okuda and Yusuke Iwasaki and Taku Yasui and Masatsugu Hori and Masatake Fukunami},
  journal={Journal of the American College of Cardiology},
  year={2009},
  volume={53 5},
  pages={426-35}
}
OBJECTIVES We prospectively compared the predictive value of cardiac iodine-123 metaiodobenzylguanidine (MIBG) imaging for sudden cardiac death (SCD) with that of the signal-averaged electrocardiogram (SAECG), heart rate variability (HRV), and QT dispersion in patients with chronic heart failure (CHF). BACKGROUND Cardiac MIBG imaging predicts prognosis of… CONTINUE READING